Bionano Genomics has appointed Alka Chaubey as its first chief medical officer, effective Aug. 31, 2020.
Chaubey, a cytogeneticist, will be responsible for driving adoption of the firm's Saphyr optical genome mapping platform for use in clinical applications.
She brings nearly 20 years of scientific and clinical experience and has developed and validated clinical tests, including US Food and Drug Administration-cleared whole-genome cyotgenetic tests. She comes to Bionano from PerkinElmer, where she is head of the cytogenomics. She is also an adjunct assistant professor of pathology at the Medical College of Georgia at Augusta University and is scientific director of the Georgia Esoteric and Molecular Laboratory and the Augusta University Medical Center cytogenetics laboratory. Before coming to PerkinElmer, she directed the Greenwood Genetic Center's cytogenomics laboratory.
Chaubey holds a doctorate in biochemistry and molecular biology from India's Guru Nanak Dev University.